Relapse after cessation of weekly tocilizumab for giant cell arteritis: a multicentre service evaluation in England

Abstract

Up to half our patients with GCA relapsed after stopping qwTCZ, often requiring a substantial increase in prednisolone dose. One-third of relapsers had a major relapse. Extended use of TCZ or repeat treatment for relapse should be considered for these patients.